A patient walks in and asks me to put her on a weekly IV schedule. She read on social media that a Myers cocktail every Friday is the foundation of "cellular wellness." She has no documented deficiencies, normal gut function, no acute condition, and a perfectly serviceable diet. The honest answer to her question is that a weekly IV is not going to do for her what she thinks it will do, and the money she would spend on it is better deployed elsewhere. That conversation is one of the more frequent ones I have around IV therapy, and it is part of why I think this article is worth writing carefully.
IV therapy is a real clinical tool with real indications. It is also one of the most aggressively marketed wellness services in the country right now, and the gap between what the marketing implies and what the evidence actually supports is wide. My seventeen years of background in emergency medicine, cardiac ICU, and cath lab work — environments where IV access and infusions are core to daily practice — shape how I think about it. Used correctly, it is valuable. Used as a default wellness habit for healthy patients, it is mostly an expensive way to get a placebo with a saline base.
The bioavailability question — what IV actually changes
IV hydration therapy bypasses the gastrointestinal tract and delivers fluids and dissolved nutrients directly into venous circulation. The advantage is bioavailability. What is infused is essentially 100 percent absorbed. Oral absorption rates for the same nutrients vary widely — vitamin C is roughly 70 to 90 percent absorbed at low oral doses but plateaus and falls below 50 percent at higher doses. B12 absorption depends on intrinsic factor and gastric acid and is impaired by PPIs, metformin, and atrophic gastritis. Magnesium oral absorption ranges from 20 to 50 percent depending on the salt form. Iron absorption depends on heme versus non-heme form, gastric acid, and concurrent nutrients.
For a patient with intact gut function and a reasonable diet, oral repletion of most nutrients works. Slower than IV, less peak-y, but the steady-state result is comparable for the cost. For a patient with documented malabsorption — post-bariatric surgery, inflammatory bowel disease, severe SIBO, short-bowel anatomy — IV is meaningfully better because the gut cannot do its job. That is the bioavailability conversation in actual clinical terms, separated from the marketing.
The other piece worth knowing: serum levels are not tissue levels. Pushing a serum vitamin level high temporarily with an IV does not necessarily translate into a long-term tissue benefit. The pharmacokinetics matter. For most water-soluble vitamins, what is not used or stored within 24 hours is excreted in urine. That bright yellow urine after a B-vitamin infusion is the body excreting what it did not need.
When IV therapy actually makes clinical sense
In my practice the indications I treat regularly with IV therapy fall into a small number of categories.
Documented absorption issues. Patients who have had bariatric surgery, particularly Roux-en-Y or biliopancreatic diversion, have permanently altered absorption that often requires lifelong supplementation, sometimes via parenteral routes. Patients with active inflammatory bowel disease in flare. Patients with severe SIBO that has not responded to standard treatment. These patients have a real reason for IV.
Acute indications. Severe dehydration that oral fluids will not correct quickly enough. Severe migraine where the speed of relief from IV magnesium and other components matters and oral medication is being vomited. Post-procedure recovery in select cases. Hangover-type presentations are commonly addressed but the evidence is largely empirical — patients consistently feel better and the risks are low, so I am comfortable offering it without overstating the science.
Documented deficiency repletion. A patient with a confirmed iron deficiency that has not corrected with oral supplementation, a patient with a documented B12 deficiency, a patient with severely low vitamin D that needs an aggressive front-loaded approach. These are repletion protocols with a defined endpoint, not indefinite wellness regimens.
Specific time-limited goals. Athletes preparing for or recovering from a major event. Patients in the recovery window after a significant surgical procedure. Patients dealing with the acute fatigue phase of a viral illness. The infusion is a discrete intervention with a discrete purpose, not a chronic habit.
Outside of these categories, the case for routine IV is weaker than the marketing suggests. I will tell patients that directly because I would rather they understand the framework than spend money on a service that is not going to do what they are hoping it will do.
The mechanism behind why people feel good after an IV — even when it is mostly placebo
Patients consistently report feeling better after an IV infusion, and the response is often genuine. Several mechanisms contribute.
The fluid load itself matters. Most adults walking around in middle Georgia in summer are mildly dehydrated. A liter of normal saline corrects that, and the immediate result is improved perfusion, reduced fatigue, and a subjective sense of feeling better. This is real, and it is also achievable with consistent oral hydration over the course of a normal day.
The setting matters. Sitting still in a comfortable chair for 45 minutes with no phone, no work, and no demands is restorative independent of what is in the bag. Many patients are getting their only true rest of the week during an infusion. That has value, but the rest is what is producing some of the benefit, not necessarily the contents of the IV.
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
Expectation matters. The placebo effect on subjective wellness is well-documented and not something to dismiss. Patients who expect to feel better often do. The clinical question is whether the felt benefit justifies the cost relative to other interventions that would produce the same or greater benefit.
Specific deficiencies, when present, do produce real changes. A patient who is genuinely magnesium-deficient will feel meaningfully better after IV magnesium. A patient who is not deficient will not. The labs answer the question.
What I look for before I recommend an IV protocol
The intake is brief but real. I want current symptom picture, recent lab work if available, current medications and supplements, prior IV therapy and the response to it, and the actual goal — what the patient is trying to accomplish.
For patients without recent labs, the deficiencies that show up most often in the workup and that are worth checking before defaulting to IV: vitamin D (almost universally low in mid-life patients in middle Georgia, despite the climate), ferritin and iron studies (women particularly), B12, magnesium (RBC magnesium is more accurate than serum), and homocysteine as a functional marker of B-vitamin status. The comprehensive wellness assessment usually reveals which oral interventions are worth optimizing first.
Specific safety screens matter for higher-risk additives. NAD+ at therapeutic doses is uncomfortable for most patients — chest tightness, nausea, flushing — and should be initiated in a clinical setting with experienced staff and a slow titration. The chest tightness is real, often alarming the first time, and patients need to be told what to expect. High-dose vitamin C requires G6PD screening before administration because patients with G6PD deficiency can develop hemolysis. Chelation protocols carry their own risk profile and are not something I do casually.
I also want to know who is administering the IV in any setting the patient is considering. The technical skill of IV placement, the sterile technique, the protocol if a patient has a reaction — these are the questions that separate a clinical setting from a medical-spa setting where IV is offered as an upsell. The risks of IV therapy are low, but they are not zero, and the difference matters when something goes wrong.
A reasonable frequency framework, by indication
For documented absorption issues, the schedule is dictated by the underlying condition and the deficiency being treated — typically every two to four weeks indefinitely with periodic lab monitoring.
For acute indications, IV is one-off or a short series within a defined window.
For documented deficiency repletion, weekly or biweekly until labs normalize, then less frequently or transitioning to oral maintenance.
For athletic recovery support around training cycles or events, situational rather than scheduled — used when there is a specific reason and a specific goal.
For wellness-only use in patients without documented deficiency, acute need, or absorption issue, my honest recommendation is usually that the dollars are better spent on the oral supplementation that addresses any actual deficiencies, on resistance training, on protein intake adequate for mid-life muscle preservation, on sleep optimization, and on addressing any underlying hormonal or metabolic issues that are producing the symptoms the patient is hoping IV will address.
Where IV therapy fits in a real wellness picture
IV therapy is one tool. It is not the foundation of wellness, and patients who are using it to substitute for sleep, nutrition, exercise, or unaddressed hormonal or metabolic issues will continue to feel suboptimal regardless of how often they sit in the infusion chair. A weekly IV does not fix the underlying issues that are producing the fatigue, brain fog, or low energy that drove the patient to ask about IV in the first place.
When the foundation is in place — sleep handled, nutrition reasonable, hormones evaluated and optimized where indicated, metabolic picture addressed — IV therapy can add value at the margins for the indications above. When the foundation is not in place, no IV protocol will substitute for it. I would rather have an honest conversation about that at the first visit than bill you for a service that is not going to deliver what you are paying for.
If you are weighing whether IV is the right tool for what you are trying to address, the next step is the intake conversation rather than booking an infusion blind. You can schedule an infusion at either the Columbus IV clinic or the Warner Robins IV clinic, and we will work through the indication, the labs that would clarify the picture, and whether the protocol you are considering is the right fit. If something else would serve you better, I will tell you that directly.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.